TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments
  • Shareholders Foundation monitors Class Action Investigations, Cases, and Class Action Settlements.
    Learn More >>>
  • Create Notifications and monitor one Case or multiple Cases. Or submit your entire portfolio! Learn More >>>

Reata Pharmaceuticals, Inc. (NASDAQ: RETA) Investor Securities Class Action Lawsuit 10/15/2020

  • If you purchased shares of Reata Pharmaceuticals, Inc. (NASDAQ: RETA), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

September 27, 2021 - The case was voluntarily dismissed. October 15, 2020 - An investor in shares of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) filed a lawsuit in the U.S. District Court for the Eastern District of Texas over alleged violations of Federal Securities Laws by Reata Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between Oc...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)